Analysis of prevailing pertussis strains from different regions in China after the application of acellular vaccines

被引：0
|
作者：
Liu, Yamin [1 ,2 ,3 ]
Jiang, Bei [2 ,3 ]
Guo, Yu [4 ]
Gao, Yuan [5 ,6 ]
Qian, Jing [2 ,3 ]
Qie, Chunhua [2 ,3 ]
Shao, Zhujun [5 ,6 ,7 ]
Li, Ying [2 ,3 ]
Wu, Qi [1 ,8 ]
机构：
[1] Tianjin Med Univ Gen Hosp, Dept Resp & Crit Care Med, Tianjin 300052, Peoples R China
[2] Tianjin Second Peoples Hosp, Inst Hepatol, Tianjin 300192, Peoples R China
[3] Tianjin Med Univ, Peoples Hosp 2, Clin Sch, Dept Infect Dis, Tianjin 300192, Peoples R China
[4] Nankai Hosp, Dept Clin Lab, Tianjin 300100, Peoples R China
[5] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China
[6] State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China
[7] Collaborat Innovat Ctr Diag & Treatment Infect Dis, Hangzhou 310005, Zhejiang, Peoples R China
[8] Tianjin Med Univ Gen Hosp, Dept Resp, Tianjin 300052, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2023年 / 136卷 / 13期
关键词：
BORDETELLA-PERTUSSIS; EPIDEMIOLOGY;
D O I：
10.1097/CM9.0000000000002244
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1618 / 1620
页数：3
相关论文
共 50 条
  • [1] Analysis of prevailing pertussis strains from different regions in China after the application of acellular vaccines
    Liu Yamin
    Jiang Bei
    Guo Yu
    Gao Yuan
    Qian Jing
    Qie Chunhua
    Shao Zhujun
    Li Ying
    Wu Qi
    中华医学杂志英文版, 2023, 136 (13)
  • [2] Acellular pertussis vaccines in China
    Wang, Lichan
    Lei, Dianliang
    Zhang, Shumin
    VACCINE, 2012, 30 (50) : 7174 - 7178
  • [3] Public health application of acellular pertussis vaccines
    Hadler, SC
    Orenstein, WA
    PERTUSSIS VACCINE TRIALS, 1997, 89 : 355 - 361
  • [4] Pertussis before and after the introduction of acellular pertussis vaccines in Finland
    Elomaa, Annika
    He, Qiushui
    Minh, Nhu Nguyen Tran
    Mertsola, Jussi
    VACCINE, 2009, 27 (40) : 5443 - 5449
  • [5] Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines
    Guiso, N
    Boursaux-Eude, C
    Weber, C
    Hausman, SZ
    Sato, H
    Iwaki, M
    Kamachi, K
    Konda, T
    Burns, DL
    VACCINE, 2001, 19 (23-24) : 3248 - 3252
  • [6] Genetic verification of Bordetella pertussis seed strains used for production of Japanese acellular pertussis vaccines
    Kamachi, Kazunari
    Fukuda, Tadashi
    Han, Hyun-Ja
    Toyoizumi-Ajisaka, Hiromi
    Mochida, Keiko
    Konda, Toshifumi
    Horiuchi, Yoshinobu
    Arakawa, Yoshichika
    BIOLOGICALS, 2010, 38 (02) : 290 - 293
  • [7] Implications of different study designs for the evaluation of acellular pertussis vaccines
    Fine, PEM
    PERTUSSIS VACCINE TRIALS, 1997, 89 : 123 - 133
  • [8] Acellular pertussis vaccines developed in Japan and their application for disease control
    Aoyama, T
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 : S264 - S269
  • [9] PRIMARY VACCINATION WITH ACELLULAR PERTUSSIS (AP) VACCINES CONTAINING DIFFERENT DOSES OF PERTUSSIS TOXOID
    JUST, M
    BOGAERTS, H
    WYNEN, J
    BOSCIA, J
    PEDIATRIC RESEARCH, 1991, 29 (04) : A159 - A159
  • [10] Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines
    Zomer, Aldert
    Otsuka, Nao
    Hiramatsu, Yukihiro
    Kamachi, Kazunari
    Nishimura, Naoko
    Ozaki, Takao
    Pooman, Jan
    Geurtsen, Jeroen
    MICROBIAL GENOMICS, 2018, 4 (05):
12345